Lucane Pharma is a company developing and commercializing medicinal products targeting rare disorders. Its product GranuPas can be used for tuberculosis treatment. Pheburane can be used for urea cycle disorder treatment, and Ucedane - for the treatment of hyperammonaemia due to N-acetylglutamate synthase primary deficiency. The company also provides regulatory, sales and marketing services.